Oncologic Interventions: Periprocedural Medications. [Review]
Citation: Seminars in Interventional Radiology. 39(4):406-410, 2022 Aug.PMID: 36406027Department: MedStar Georgetown University Hospital/MedStar Washington Hospital Center | Radiology/Interventional Integrated ResidencyForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2022ISSN:- 0739-9529
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 36406027 | Available | 36406027 |
Significant advances in ablative and endovascular therapies have allowed interventional radiology to play a substantial role in the management of patients with malignant neoplasms. The evolution of these procedures and the optimization of patient outcomes and experience must take into account various elements of the periprocedural period. Some of the most important considerations within the periprocedural period are the pharmacologic agents used to avoid infectious complications, decrease pain, and manage side effects. In this article, we discuss some of the most commonly used medications in interventional oncology procedures including antibiotics, narcotics, sedatives, antiemetics, and others. Copyright Thieme. All rights reserved.
English